Today in France, 1 person in every 300 suffers
from inherited hypercholesterolemia
The CHOPIN translational research project seeks to reduce cardiovascular risks
in patients by offering new personalised hypercholesterolemia treatment
through the identification of new risk markers and therapeutic targets.
NEWS
Academic and Industry partners
Clinical trials over 5 years
Patients involved
million euros obtained via the RHU call for projects
COORDINATION :


